Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03091075 · ClinicalTrials.gov registry record · NA
Oxandrolone Rotator Cuff Trial
A NA study of Rotator Cuff Tear, sponsored by University of Southern California.
- Active
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT03091075 is a NA study of Rotator Cuff Tear that is active but no longer recruiting, run by University of Southern California. The registered enrollment target is 116 participants, above the 83-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (40% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03091075, a NA study of Rotator Cuff Tear, is active but no longer recruiting, sponsored by University of Southern California.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is about healing after a rotator cuff tear repair procedure. We hope to learn if a biologic medication: Oxandrolone, a synthetic derivative of the human hormone Testosterone (the principal male sex hormone and an anabolic steroid), given for 12 weeks following rotator cuff repair, is effective in aiding in the healing process and restoring muscle mass.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Oxandrolone
Study Locations (1)
California
- Keck School of Medicine of the University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2018-09-23 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03091075
The ClinicalTrials.gov registry entry for NCT03091075 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 83-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (40% higher). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rotator Cuff Tear appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03091075 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03091075 about?
NCT03091075 is a clinical study titled "Oxandrolone Rotator Cuff Trial". This study is about healing after a rotator cuff tear repair procedure. We hope to learn if a biologic medication: Oxandrolone, a synthetic derivative of the human hormone Testosterone (the principal male sex hormone and an anabolic steroid), given for 12 weeks following rotator cuff repair, is effe...
What is the current status of trial NCT03091075?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2018-09-23. Estimated completion is 2025-12.
What conditions does trial NCT03091075 study?
This clinical trial studies the following conditions: Rotator Cuff Tear.
What interventions are being tested in trial NCT03091075?
The interventions under investigation include: Placebo (DRUG), Oxandrolone (DRUG).
Who is sponsoring clinical trial NCT03091075?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03091075 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
ACTIVE NOT RECRUITING · NA
-
Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears
COMPLETED · NA
-
Vascular Changes of Rotator Cuff Repair Augmented With a Whole Blood Fibrin Clot
COMPLETED · NA
-
BioWick SureLock Clinical Outcomes Study
COMPLETED · NA
-
Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.